Specific cancer cells including gliomas, secondary glioblastomas, and acute myeloid leukemia (AML) overproduce D-2-Hydroxyglutarate (D-2HG) due to point mutations in cytosolic Isocitrate Dehydrogenase 1 (IDH1) (1). Here, IDH1 is linked to acute myeloid leukemia.